Medidata Solutions Inc (NASDAQ:MDSO) Shares Bought by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC grew its holdings in Medidata Solutions Inc (NASDAQ:MDSO) by 0.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 844,144 shares of the company’s stock after purchasing an additional 4,305 shares during the period. Conestoga Capital Advisors LLC owned about 1.36% of Medidata Solutions worth $61,825,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the business. BlackRock Inc. raised its stake in shares of Medidata Solutions by 2.9% in the fourth quarter. BlackRock Inc. now owns 6,995,601 shares of the company’s stock worth $471,644,000 after purchasing an additional 195,763 shares during the last quarter. Vanguard Group Inc. raised its position in Medidata Solutions by 2.8% during the third quarter. Vanguard Group Inc. now owns 5,200,744 shares of the company’s stock valued at $381,266,000 after acquiring an additional 142,687 shares in the last quarter. Vanguard Group Inc raised its position in Medidata Solutions by 2.8% during the third quarter. Vanguard Group Inc now owns 5,200,744 shares of the company’s stock valued at $381,266,000 after acquiring an additional 142,687 shares in the last quarter. Clearbridge Investments LLC raised its position in Medidata Solutions by 5.9% during the third quarter. Clearbridge Investments LLC now owns 2,429,627 shares of the company’s stock valued at $178,116,000 after acquiring an additional 135,078 shares in the last quarter. Finally, Canada Pension Plan Investment Board raised its position in Medidata Solutions by 1.3% during the fourth quarter. Canada Pension Plan Investment Board now owns 1,108,300 shares of the company’s stock valued at $74,715,000 after acquiring an additional 13,700 shares in the last quarter.

Several analysts have commented on MDSO shares. Wells Fargo & Co lowered Medidata Solutions from an “outperform” rating to a “market perform” rating and set a $90.00 price objective on the stock. in a report on Tuesday, April 23rd. SunTrust Banks lowered Medidata Solutions from a “buy” rating to a “hold” rating and set a $79.00 price objective on the stock. in a report on Wednesday, April 24th. William Blair initiated coverage on Medidata Solutions in a research note on Monday, April 15th. They issued an “outperform” rating and a $74.93 price target on the stock. Zacks Investment Research lowered Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Monday, January 28th. Finally, Piper Jaffray Companies lifted their price target on Medidata Solutions from $83.00 to $96.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 30th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. Medidata Solutions has a consensus rating of “Hold” and an average price target of $84.28.

Shares of MDSO stock traded up $0.72 on Friday, hitting $93.54. The stock had a trading volume of 670,446 shares, compared to its average volume of 1,337,686. The company has a current ratio of 2.57, a quick ratio of 2.71 and a debt-to-equity ratio of 0.14. The company has a market capitalization of $5.78 billion, a PE ratio of 97.44, a P/E/G ratio of 8.42 and a beta of 1.42. Medidata Solutions Inc has a 1 year low of $60.10 and a 1 year high of $98.60.

Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $0.45 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.12 by $0.33. Medidata Solutions had a return on equity of 9.28% and a net margin of 7.99%. The company had revenue of $173.50 million for the quarter, compared to the consensus estimate of $172.12 million. During the same quarter in the prior year, the business earned $0.40 EPS. Medidata Solutions’s revenue was up 16.3% on a year-over-year basis. Research analysts predict that Medidata Solutions Inc will post 0.79 EPS for the current fiscal year.

In other news, EVP Daniel Patrick Shannon sold 19,725 shares of the company’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $75.17, for a total transaction of $1,482,728.25. Following the completion of the transaction, the executive vice president now directly owns 70,497 shares of the company’s stock, valued at approximately $5,299,259.49. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Michael Pray sold 15,000 shares of the company’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $76.50, for a total value of $1,147,500.00. Following the transaction, the executive vice president now directly owns 77,134 shares of the company’s stock, valued at $5,900,751. The disclosure for this sale can be found here. 4.70% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This news story was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/05/11/medidata-solutions-inc-mdso-shares-bought-by-conestoga-capital-advisors-llc.html.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Further Reading: Capital gains and your 401(k) or IRA

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.